BENEFITS AND SIDE EFFECTS OF MEDICATIONS
Keywords:
Antipsychotics, corticosteroids, antidiabetic medications, side effects, metabolic disorders, immune suppression, psychosis, insulin therapy, patient safety.Abstract
Antipsychotic medications, corticosteroids, and antidiabetic drugs are essential for managing various mental and physical health conditions. Antipsychotics help treat schizophrenia, bipolar disorder, and psychotic disorders by regulating neurotransmitters but may cause metabolic issues and neurological side effects. Corticosteroids provide potent anti-inflammatory and immunosuppressive benefits but carry risks such as osteoporosis, weight gain, and immune suppression. Antidiabetic medications, including insulin and oral agents, control blood sugar levels, reducing diabetes complications while posing risks such as hypoglycemia and gastrointestinal disturbances. Careful monitoring, lifestyle modifications, and patient education are crucial for balancing therapeutic benefits with potential adverse effects.
References
1. Stahl, S. M. (2021). Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (5th ed.). Cambridge University Press.
2. American Psychiatric Association. (2020). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. American Psychiatric Publishing.
3. Lieberman, J. A., & First, M. B. (2018). Psychotic Disorders: A Practical Guide. Oxford University Press.
4. Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2017). Goodman & Gilman’s: The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education.
5. Rosenberg, J. M. (2019). Antipsychotic Drug Effects and Treatment Approaches: A Comprehensive Review. Journal of Clinical Psychopharmacology, 39(4), 322-335. DOI: https://doi.org/10.1097/JCP.0000000000001072
6. Furst, D. E. (2019). Glucocorticoid Therapy: Pharmacology and Side Effects. Rheumatic Disease Clinics of North America, 45(3), 1-14. DOI: https://doi.org/10.1016/j.rdc.2019.03.008
7. American Diabetes Association. (2023). Standards of Medical Care in Diabetes—2023. Diabetes Care, 46(Supplement_1), S1-S280. DOI: https://doi.org/10.2337/dc23-S001
8. DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., & Weiss, R. (2015). Type 2 Diabetes Mellitus. Nature Reviews Disease Primers, 1, 15019. DOI: https://doi.org/10.1038/nrdp.2015.19
9. World Health Organization. (2022). Global Guidelines for Pharmacological Treatment of Mental, Neurological, and Substance Use Disorders. Retrieved from https://www.who.int
10. National Institute for Health and Care Excellence (NICE). (2023). Management of Type 2 Diabetes and Antidiabetic Medications. Retrieved from https://www.nice.org.uk
